ARGX-113-2301 (UplighTED) - Clinical Trial
¿Cuál es el Propósito de este estudio?
In this study, people will be randomly chosen to get either a medicine called efgartigimod or a placebo. A placebo looks like the real medicine but does not have any medicine in it. It is used to help compare results.
There is a 67% chance of getting efgartigimod and a 33% chance of getting the placebo. That means twice as many people will get the real medicine.
The study will last about 1 to 2 years, depending on how each person reacts to the medicine. People will need to visit the study clinic up to 20 times for tests and check-ups.
Thyroid Eye Disease
¿Quién puede participar en el Estudio?
People in this study must:
- Be 18 years old or older.
- Have active Thyroid Eye Disease (TED) that is linked to Graves' disease or Hashimoto's thyroiditis.
- Not have had radiation or surgery to treat TED before.
¿Qué Implica?
This study is trying to find out if a new medicine called efgartigimod can help people who have Thyroid Eye Disease, or TED. The study also wants to make sure the medicine is safe for people to use.
Detalles del Estudio
